“Using Regression Trees to Predict the Development of Immune-Mediated Adverse Events in Patients Receiving Immune Checkpoint Inhibitor Therapy”. 2024. Voprosy Onkologii 70 (4): 677-84. https://doi.org/10.37469/0507-3758-2024-70-4-677-684.